[English] 日本語
Yorodumi- EMDB-73160: Constituent EM map: Focused refinement on JSol+CSol of mouse RyR1... -
+
Open data
-
Basic information
| Entry | ![]() | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Title | Constituent EM map: Focused refinement on JSol+CSol of mouse RyR1 (Ca2+/CFF/ATP dataset; open pore) | |||||||||
Map data | Constituent EM map: Focused refinement on JSol/CSol of mouse RyR1 (Ca/CFF/ATP dataset; open pore) | |||||||||
Sample |
| |||||||||
Keywords | Calcium / Ion Channel / Membrane Protein | |||||||||
| Biological species | ![]() | |||||||||
| Method | single particle reconstruction / cryo EM / Resolution: 2.7 Å | |||||||||
Authors | Weninger G / Marks AR | |||||||||
| Funding support | United States, 1 items
| |||||||||
Citation | Journal: J Clin Invest / Year: 2025Title: Structural basis for simvastatin-induced skeletal muscle weakness associated with type 1 ryanodine receptor T4709M mutation. Authors: Gunnar Weninger / Haikel Dridi / Steven Reiken / Qi Yuan / Nan Zhao / Linda Groom / Jennifer Leigh / Yang Liu / Carl Tchagou / Jiayi Kang / Alexander Chang / Estefania Luna-Figueroa / Marco ...Authors: Gunnar Weninger / Haikel Dridi / Steven Reiken / Qi Yuan / Nan Zhao / Linda Groom / Jennifer Leigh / Yang Liu / Carl Tchagou / Jiayi Kang / Alexander Chang / Estefania Luna-Figueroa / Marco C Miotto / Anetta Wronska / Robert T Dirksen / Andrew R Marks / ![]() Abstract: Statins lower cholesterol, reducing the risk of heart disease, and are among the most frequently prescribed drugs. Approximately 10% of individuals develop statin-associated muscle symptoms (SAMS; ...Statins lower cholesterol, reducing the risk of heart disease, and are among the most frequently prescribed drugs. Approximately 10% of individuals develop statin-associated muscle symptoms (SAMS; myalgias, rhabdomyolysis, and muscle weakness), often rendering them statin intolerant. The mechanism underlying SAMS remains poorly understood. Patients with mutations in the skeletal muscle ryanodine receptor 1 (RyR1)/calcium release channel can be particularly intolerant of statins. High-resolution structures revealed simvastatin binding sites in the pore region of RyR1. Simvastatin stabilized the open conformation of the pore and activated the RyR1 channel. In a mouse expressing a mutant RyR1-T4709M found in a patient with profound statin intolerance, simvastatin caused muscle weakness associated with leaky RyR1 channels. Cotreatment with a Rycal drug that stabilizes the channel closed state prevented simvastatin-induced muscle weakness. Thus, statin binding to RyR1 can cause SAMS, and patients with RyR1 mutations may represent a high-risk group for statin intolerance. | |||||||||
| History |
|
-
Structure visualization
| Supplemental images |
|---|
-
Downloads & links
-EMDB archive
| Map data | emd_73160.map.gz | 256.1 MB | EMDB map data format | |
|---|---|---|---|---|
| Header (meta data) | emd-73160-v30.xml emd-73160.xml | 17.4 KB 17.4 KB | Display Display | EMDB header |
| FSC (resolution estimation) | emd_73160_fsc.xml | 16.9 KB | Display | FSC data file |
| Images | emd_73160.png | 49.7 KB | ||
| Filedesc metadata | emd-73160.cif.gz | 4.4 KB | ||
| Others | emd_73160_half_map_1.map.gz emd_73160_half_map_2.map.gz | 475.1 MB 475.1 MB | ||
| Archive directory | http://ftp.pdbj.org/pub/emdb/structures/EMD-73160 ftp://ftp.pdbj.org/pub/emdb/structures/EMD-73160 | HTTPS FTP |
-Validation report
| Summary document | emd_73160_validation.pdf.gz | 1.2 MB | Display | EMDB validaton report |
|---|---|---|---|---|
| Full document | emd_73160_full_validation.pdf.gz | 1.2 MB | Display | |
| Data in XML | emd_73160_validation.xml.gz | 26 KB | Display | |
| Data in CIF | emd_73160_validation.cif.gz | 34.1 KB | Display | |
| Arichive directory | https://ftp.pdbj.org/pub/emdb/validation_reports/EMD-73160 ftp://ftp.pdbj.org/pub/emdb/validation_reports/EMD-73160 | HTTPS FTP |
-Related structure data
-
Links
| EMDB pages | EMDB (EBI/PDBe) / EMDataResource |
|---|
-
Map
| File | Download / File: emd_73160.map.gz / Format: CCP4 / Size: 512 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | Constituent EM map: Focused refinement on JSol/CSol of mouse RyR1 (Ca/CFF/ATP dataset; open pore) | ||||||||||||||||||||||||||||||||||||
| Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
| Voxel size | X=Y=Z: 0.83 Å | ||||||||||||||||||||||||||||||||||||
| Density |
| ||||||||||||||||||||||||||||||||||||
| Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
| Details | EMDB XML:
|
-Supplemental data
-Half map: #2
| File | emd_73160_half_map_1.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-Half map: #1
| File | emd_73160_half_map_2.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-
Sample components
-Entire : Complex of RyR1 with Calstabin-1 (Ca2+/CFF/ATP condition)
| Entire | Name: Complex of RyR1 with Calstabin-1 (Ca2+/CFF/ATP condition) |
|---|---|
| Components |
|
-Supramolecule #1: Complex of RyR1 with Calstabin-1 (Ca2+/CFF/ATP condition)
| Supramolecule | Name: Complex of RyR1 with Calstabin-1 (Ca2+/CFF/ATP condition) type: complex / ID: 1 / Parent: 0 / Details: 0.03 mM free Ca2+; 5 mM Caffeine; 10 mM ATP |
|---|---|
| Source (natural) | Organism: ![]() |
-Experimental details
-Structure determination
| Method | cryo EM |
|---|---|
Processing | single particle reconstruction |
| Aggregation state | particle |
-
Sample preparation
| Concentration | 8.5 mg/mL | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buffer | pH: 7.4 Component:
| |||||||||||||||||||||
| Vitrification | Cryogen name: ETHANE / Chamber humidity: 100 % / Chamber temperature: 277.15 K / Instrument: FEI VITROBOT MARK IV |
-
Electron microscopy
| Microscope | TFS KRIOS |
|---|---|
| Image recording | Film or detector model: GATAN K3 BIOQUANTUM (6k x 4k) / Number grids imaged: 1 / Number real images: 4695 / Average electron dose: 58.0 e/Å2 |
| Electron beam | Acceleration voltage: 300 kV / Electron source: FIELD EMISSION GUN |
| Electron optics | C2 aperture diameter: 100.0 µm / Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Cs: 2.7 mm / Nominal defocus max: 1.2 µm / Nominal defocus min: 0.5 µm |
| Sample stage | Specimen holder model: FEI TITAN KRIOS AUTOGRID HOLDER / Cooling holder cryogen: NITROGEN |
| Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
Movie
Controller
About Yorodumi



Keywords
Authors
United States, 1 items
Citation

































Z (Sec.)
Y (Row.)
X (Col.)




































Processing
FIELD EMISSION GUN

